-
Salzman C. Antipsychotics in nursing homes. J Clin Psychopharmacol. 2013 Feb; 33(1):1-2.
-
Salzman C, Seidman LJ, Keshavan MS. The Massachusetts Mental Health Center: going forward after 100 years. Am J Psychiatry. 2012 Oct; 169(10):1037.
-
Salzman C. Alexander (Sandy) H. Glassman, MD. J Clin Psychopharmacol. 2011 Dec; 31(6):688-9.
-
Lu CY, Adams AS, Ross-Degnan D, Zhang F, Zhang Y, Salzman C, Soumerai SB. Association between prior authorization for medications and health service use by Medicaid patients with bipolar disorder. Psychiatr Serv. 2011 Feb; 62(2):186-93.
-
Salzman C, Glick I, Keshavan MS. The 7 sins of psychopharmacology. J Clin Psychopharmacol. 2010 Dec; 30(6):653-5.
-
Salzman C. What is a geriatric psychopharmacologist to do? J Clin Psychopharmacol. 2010 Oct; 30(5):485-6.
-
Meyer RE, Salzman C, Youngstrom EA, Clayton PJ, Goodwin FK, Mann JJ, Alphs LD, Broich K, Goodman WK, Greden JF, Meltzer HY, Normand SL, Posner K, Shaffer D, Oquendo MA, Stanley B, Trivedi MH, Turecki G, Beasley CM, Beautrais AL, Bridge JA, Brown GK, Revicki DA, Ryan ND, Sheehan DV. Suicidality and risk of suicide--definition, drug safety concerns, and a necessary target for drug development: a consensus statement. J Clin Psychiatry. 2010 Aug; 71(8):e1-e21.
-
Meyer RE, Salzman C, Youngstrom EA, Clayton PJ, Goodwin FK, Mann JJ, Alphs LD, Broich K, Goodman WK, Greden JF, Meltzer HY, Normand SL, Posner K, Shaffer D, Oquendo MA, Stanley B, Trivedi MH, Turecki G, Beasley CM, Beautrais AL, Bridge JA, Brown GK, Revicki DA, Ryan ND, Sheehan DV. Suicidality and risk of suicide--definition, drug safety concerns, and a necessary target for drug development: a brief report. J Clin Psychiatry. 2010 Aug; 71(8):1040-6.
-
Morrison SE, Salzman CD. Re-valuing the amygdala. Curr Opin Neurobiol. 2010 Apr; 20(2):221-30.
-
Rigotti M, Ben Dayan Rubin D, Morrison SE, Salzman CD, Fusi S. Attractor concretion as a mechanism for the formation of context representations. Neuroimage. 2010 Sep; 52(3):833-47.
-
Salzman CD, Fusi S. Emotion, cognition, and mental state representation in amygdala and prefrontal cortex. Annu Rev Neurosci. 2010; 33:173-202.
-
Morrison SE, Salzman CD. The convergence of information about rewarding and aversive stimuli in single neurons. J Neurosci. 2009 Sep 16; 29(37):11471-83.
-
Belova MA, Paton JJ, Salzman CD. Moment-to-moment tracking of state value in the amygdala. J Neurosci. 2008 Oct 1; 28(40):10023-30.
-
Lau B, Salzman CD. Noncholinergic neurons in the basal forebrain: often neglected but motivationally salient. Neuron. 2008 Jul 10; 59(1):6-8.
-
Salzman C, Jeste DV, Meyer RE, Cohen-Mansfield J, Cummings J, Grossberg GT, Jarvik L, Kraemer HC, Lebowitz BD, Maslow K, Pollock BG, Raskind M, Schultz SK, Wang P, Zito JM, Zubenko GS. Elderly patients with dementia-related symptoms of severe agitation and aggression: consensus statement on treatment options, clinical trials methodology, and policy. J Clin Psychiatry. 2008 Jun; 69(6):889-98.
-
Zisook S, Glick ID, Jefferson JW, Wagner KD, Salzman C, Peselow ED, Stahl S. Teaching psychopharmacology: what works and what doesn't. J Clin Psychopharmacol. 2008 Feb; 28(1):96-100.
-
Salzman C. Pharmacologic treatment of disturbed sleep in the elderly. Harv Rev Psychiatry. 2008; 16(5):271-8.
-
Ancoli-Israel S, Ayalon L, Salzman C. Sleep in the elderly: normal variations and common sleep disorders. Harv Rev Psychiatry. 2008; 16(5):279-86.
-
Rosenberg JM, Salzman C. Update: new uses for lithium and anticonvulsants. CNS Spectr. 2007 Nov; 12(11):831-41.
-
Nelson JC, Holden K, Roose S, Salzman C, Hollander SB, Betzel JV. Are there predictors of outcome in depressed elderly nursing home residents during treatment with mirtazapine orally disintegrating tablets? Int J Geriatr Psychiatry. 2007 Oct; 22(10):999-1003.
-
Belova MA, Paton JJ, Morrison SE, Salzman CD. Expectation modulates neural responses to pleasant and aversive stimuli in primate amygdala. Neuron. 2007 Sep 20; 55(6):970-84.
-
Salzman CD, Paton JJ, Belova MA, Morrison SE. Flexible neural representations of value in the primate brain. Ann N Y Acad Sci. 2007 Dec; 1121:336-54.
-
Jeste DV, Blazer D, Casey D, Meeks T, Salzman C, Schneider L, Tariot P, Yaffe K. ACNP White Paper: update on use of antipsychotic drugs in elderly persons with dementia. Neuropsychopharmacology. 2008 Apr; 33(5):957-70.
-
Salzman C, Rosenberg J, Feldman JJ. Schizophrenia symptoms remain stable during decreases from 2 antipsychotics to aripiprazole. J Clin Psychiatry. 2007 Jun; 68(6):970.
-
Glick ID, Salzman C, Cohen BM, Klein DF, Moutier C, Nasrallah HA, Ongur D, Wang P, Zisook S. Improving the pedagogy associated with the teaching of psychopharmacology. Acad Psychiatry. 2007 May-Jun; 31(3):211-7.
-
Pearson SA, Soumerai S, Mah C, Zhang F, Simoni-Wastila L, Salzman C, Cosler LE, Fanning T, Gallagher P, Ross-Degnan D. Racial disparities in access after regulatory surveillance of benzodiazepines. Arch Intern Med. 2006 Mar 13; 166(5):572-9.
-
Paton JJ, Belova MA, Morrison SE, Salzman CD. The primate amygdala represents the positive and negative value of visual stimuli during learning. Nature. 2006 Feb 16; 439(7078):865-70.
-
Salzman C. A 60-year-old woman who has felt sad for much of her life. JAMA. 2006 Jan 18; 295(3):318-23.
-
Salzman CD, Belova MA, Paton JJ. Beetles, boxes and brain cells: neural mechanisms underlying valuation and learning. Curr Opin Neurobiol. 2005 Dec; 15(6):721-9.
-
Brooke NS, Wiersgalla M, Salzman C. Atypical uses of atypical antipsychotics. Harv Rev Psychiatry. 2005 Nov-Dec; 13(6):317-39.
-
Jeste DV, Dolder CR, Nayak GV, Salzman C. Atypical antipsychotics in elderly patients with dementia or schizophrenia: review of recent literature. Harv Rev Psychiatry. 2005 Nov-Dec; 13(6):340-51.
-
Salzman C. The limited role of expert guidelines in teaching psychopharmacology. Acad Psychiatry. 2005 May-Jun; 29(2):176-9.
-
Salzman C. Clinical Geriatric Psychopharmacology. 2005.
-
Simoni-Wastila L, Ross-Degnan D, Mah C, Gao X, Brown J, Cosler LE, Fanning T, Gallagher P, Salzman C, Soumerai SB. A retrospective data analysis of the impact of the New York triplicate prescription program on benzodiazepine use in medicaid patients with chronic psychiatric and neurologic disorders. Clin Ther. 2004 Feb; 26(2):322-36.
-
Salzman C. Late-life anxiety disorders. Psychopharmacol Bull. 2004; 38(1):25-30.
-
Ross-Degnan D, Simoni-Wastila L, Brown JS, Gao X, Mah C, Cosler LE, Fanning T, Gallagher P, Salzman C, Shader RI, Inui TS, Soumerai SB. A controlled study of the effects of state surveillance on indicators of problematic and non-problematic benzodiazepine use in a Medicaid population. Int J Psychiatry Med. 2004; 34(2):103-23.
-
Salzman C. Late-life anxiety disorders. Psychopharmacol Bull. 2004; 38 Suppl 1:25-30.
-
Salzman C. New uses for lithium and anticonvulsants. Harv Rev Psychiatry. 2003 Sep-Oct; 11(5):230-44.
-
Bruce SE, Vasile RG, Goisman RM, Salzman C, Spencer M, Machan JT, Keller MB. Are benzodiazepines still the medication of choice for patients with panic disorder with or without agoraphobia? Am J Psychiatry. 2003 Aug; 160(8):1432-8.
-
Charney DS, Reynolds CF, Lewis L, Lebowitz BD, Sunderland T, Alexopoulos GS, Blazer DG, Katz IR, Meyers BS, Arean PA, Borson S, Brown C, Bruce ML, Callahan CM, Charlson ME, Conwell Y, Cuthbert BN, Devanand DP, Gibson MJ, Gottlieb GL, Krishnan KR, Laden SK, Lyketsos CG, Mulsant BH, Niederehe G, Olin JT, Oslin DW, Pearson J, Persky T, Pollock BG, Raetzman S, Reynolds M, Salzman C, Schulz R, Schwenk TL, Scolnick E, Unutzer J, Weissman MM, Young RC. Depression and Bipolar Support Alliance consensus statement on the unmet needs in diagnosis and treatment of mood disorders in late life. Arch Gen Psychiatry. 2003 Jul; 60(7):664-72.
-
Soumerai SB, Simoni-Wastila L, Singer C, Mah C, Gao X, Salzman C, Ross-Degnan D. Lack of relationship between long-term use of benzodiazepines and escalation to high dosages. Psychiatr Serv. 2003 Jul; 54(7):1006-11.
-
Tune LE, Salzman C. Schizophrenia in late life. Psychiatr Clin North Am. 2003 Mar; 26(1):103-13.
-
Roose SP, Nelson JC, Salzman C, Hollander SB, Rodrigues H. Open-label study of mirtazapine orally disintegrating tablets in depressed patients in the nursing home. Curr Med Res Opin. 2003; 19(8):737-46.
-
Salzman C, Wong E, Wright BC. Drug and ECT treatment of depression in the elderly, 1996-2001: a literature review. Biol Psychiatry. 2002 Aug 1; 52(3):265-84.
-
Burrows AB, Salzman C, Satlin A, Noble K, Pollock BG, Gersh T. A randomized, placebo-controlled trial of paroxetine in nursing home residents with non-major depression. Depress Anxiety. 2002; 15(3):102-10.
-
McDonald WM, Salzman C, Schatzberg AF. Depression in the elderly. Psychopharmacol Bull. 2002; 36 Suppl 2:112-22.
-
Salzman C. Substance P in depression. Harv Ment Health Lett. 2001 Dec; 18(6):7.
-
Silvestri R, Pace-Schott EF, Gersh T, Stickgold R, Salzman C, Hobson JA. Effects of fluvoxamine and paroxetine on sleep structure in normal subjects: a home-based Nightcap evaluation during drug administration and withdrawal. J Clin Psychiatry. 2001 Aug; 62(8):642-52.
-
Pace-Schott EF, Gersh T, Silvestri R, Stickgold R, Salzman C, Hobson JA. SSRI treatment suppresses dream recall frequency but increases subjective dream intensity in normal subjects. J Sleep Res. 2001 Jun; 10(2):129-42.
-
Salzman C, Tune L. Neuroleptic treatment of late-life schizophrenia. Harv Rev Psychiatry. 2001 Mar-Apr; 9(2):77-83.
-
Salzman C, Goldenberg I, Bruce SE, Keller MB. Pharmacologic treatment of anxiety disorders in 1989 versus 1996: results from the Harvard/Brown anxiety disorders research program. J Clin Psychiatry. 2001 Mar; 62(3):149-52.
-
Salzman C. Treatment of the agitation of late-life psychosis and Alzheimer's disease. Eur Psychiatry. 2001 Jan; 16 Suppl 1:25s-28s.
-
Salzman C. Psychiatric Medications for Older Adults. 2001.
-
Tariot PN, Salzman C, Yeung PP, Pultz J, Rak IW. Long-Term use of quetiapine in elderly patients with psychotic disorders. Clin Ther. 2000 Sep; 22(9):1068-84.
-
Echols JC, Naidoo U, Salzman C. SAMe (S-adenosylmethionine). Harv Rev Psychiatry. 2000 Jul-Aug; 8(2):84-90.
-
Salzman C. Cognitive improvement after benzodiazepine discontinuation. J Clin Psychopharmacol. 2000 Feb; 20(1):99.
-
Salzman C. What are the risks of benzodiazepine dependence? Harv Ment Health Lett. 1999 Jul; 16(1):8.
-
Salzman C. Not all psychiatric research is bad. Am J Psychiatry. 1999 Jul; 156(7):987-8.
-
Cerulli TR, Alkoc SC, Salzman C. Effects of psychotropic medications on pancreatic function: a review. Harv Rev Psychiatry. 1999 May-Jun; 7(1):54-60.
-
Salzman C. An 87-year-old woman taking a benzodiazepine. JAMA. 1999 Mar 24-31; 281(12):1121-5.
-
Salzman C. Practical considerations for the treatment of depression in elderly and very elderly long-term care patients. J Clin Psychiatry. 1999; 60 Suppl 20:30-3.
-
Fava M, Amsterdam JD, Deltito JA, Salzman C, Schwaller M, Dunner DL. A double-blind study of paroxetine, fluoxetine, and placebo in outpatients with major depression. Ann Clin Psychiatry. 1998 Dec; 10(4):145-50.
-
Salzman C. Integrating pharmacotherapy and psychotherapy in the treatment of a bipolar patient. Am J Psychiatry. 1998 May; 155(5):686-8.
-
Salzman C. St. John's wort. Harv Rev Psychiatry. 1998 Mar-Apr; 5(6):333-5.
-
Salzman C. ECT, research, and professional ambivalence. Am J Psychiatry. 1998 Jan; 155(1):1-2.
-
Salzman C. Clinical Geriatric Psychopharmacology. 1998.
-
Salzman C. Addiction to benzodiazepines. Psychiatr Q. 1998; 69(4):251-61.
-
Salzman C. Depressive disorders and other emotional issues in the elderly: current issues. Int Clin Psychopharmacol. 1997 Dec; 12 Suppl 7:S37-42.
-
Patel JK, Salzman C, Green AI, Tsuang MT. Chronic schizophrenia: response to clozapine, risperidone, and paroxetine. Am J Psychiatry. 1997 Apr; 154(4):543-6.
-
Salzman C. The benzodiazepine controversy: therapeutic effects versus dependence, withdrawal, and toxicity. Harv Rev Psychiatry. 1997 Jan-Feb; 4(5):279-82.
-
Salzman C. Heterogeneity of SSRI response. Harv Rev Psychiatry. 1996 Nov-Dec; 4(4):215-7.
-
Salzman C. Sexual abuse and borderline personality disorder. Am J Psychiatry. 1996 Jun; 153(6):848-9.
-
Sheikh JI, Salzman C. Anxiety in the elderly. Course and treatment. Psychiatr Clin North Am. 1995 Dec; 18(4):871-83.
-
Burrows AB, Satlin A, Salzman C, Nobel K, Lipsitz LA. Depression in a long-term care facility: clinical features and discordance between nursing assessment and patient interviews. J Am Geriatr Soc. 1995 Oct; 43(10):1118-22.
-
Fox HA, Salzman C. Resistant depression in the very old--a role for maintenance ECT? Harv Rev Psychiatry. 1995 Sep-Oct; 3(3):152-5.
-
Longo LP, Salzman C. Valproic acid effects on serum concentrations of clozapine and norclozapine. Am J Psychiatry. 1995 Apr; 152(4):650.
-
Dantzler A, Salzman C. Treatment of bipolar depression. Psychiatr Serv. 1995 Mar; 46(3):229-30.
-
Salzman C, Wolfson AN, Schatzberg A, Looper J, Henke R, Albanese M, Schwartz J, Miyawaki E. Effect of fluoxetine on anger in symptomatic volunteers with borderline personality disorder. J Clin Psychopharmacol. 1995 Feb; 15(1):23-9.
-
Salzman C. Medication compliance in the elderly. J Clin Psychiatry. 1995; 56 Suppl 1:18-22; discussion 23.
-
Green AI, Zalma A, Berman I, DuRand CJ, Salzman C. Clozapine following ECT: a two-step treatment. J Clin Psychiatry. 1994 Sep; 55(9):388-90.
-
Land W, Salzman C. Risperidone: a novel antipsychotic medication. Hosp Community Psychiatry. 1994 May; 45(5):434-5.
-
Kingsbury SJ, Salzman C. Lithium's role in hyperparathyroidism and hypercalcemia. Hosp Community Psychiatry. 1993 Nov; 44(11):1047-8.
-
Salzman C, Miyawaki EK, le Bars P, Kerrihard TN. Neurobiologic basis of anxiety and its treatment. Harv Rev Psychiatry. 1993 Nov-Dec; 1(4):197-206.
-
Salzman C, Jimerson D, Vasile R, Watsky E, Gerber J. Response to SSRI antidepressants correlates with reduction in plasma HVA: pilot study. Biol Psychiatry. 1993 Oct 15; 34(8):569-71.
-
Salzman JP, Salzman C, Wolfson AN, Albanese M, Looper J, Ostacher M, Schwartz J, Chinman G, Land W, Miyawaki E. Association between borderline personality structure and history of childhood abuse in adult volunteers. Compr Psychiatry. 1993 Jul-Aug; 34(4):254-7.
-
Green AI, Alam MY, Sobieraj JT, Pappalardo KM, Waternaux C, Salzman C, Schatzberg AF, Schildkraut JJ. Clozapine response and plasma catecholamines and their metabolites. Psychiatry Res. 1993 Feb; 46(2):139-49.
-
Salzman C. Pharmacologic treatment of depression in the elderly. J Clin Psychiatry. 1993 Feb; 54 Suppl:23-8.
-
Salzman C. Issues and controversies regarding benzodiazepine use. NIDA Res Monogr. 1993; 131:68-88.
-
Salzman C. Benzodiazepine treatment of panic and agoraphobic symptoms: use, dependence, toxicity, abuse. J Psychiatr Res. 1993; 27 Suppl 1:97-110.
-
Glick ID, Janowsky DS, Salzman C, Shader RI. A proposal for a model psychopharmacology curriculum for psychiatric residents. Neuropsychopharmacology. 1993 Jan; 8(1):1-5.
-
Salzman C. The current status of fluoxetine. Neuropsychopharmacology. 1992 Dec; 7(4):245-7.
-
Berman H, Sapers BL, Salzman C. Sertraline: a new serotonergic antidepressant. Hosp Community Psychiatry. 1992 Jul; 43(7):671-2.
-
Salzman C. Monoamine oxidase inhibitors and atypical antidepressants. Clin Geriatr Med. 1992 May; 8(2):335-48.
-
Salzman C. Clinical Geriatric Psychopharmacology. 1992.
-
Smith BD, Salzman C. Do benzodiazepines cause depression? Hosp Community Psychiatry. 1991 Nov; 42(11):1101-2.
-
Land W, Pinsky D, Salzman C. Abuse and misuse of anticholinergic medications. Hosp Community Psychiatry. 1991 Jun; 42(6):580-1.
-
Salzman C, Solomon D, Miyawaki E, Glassman R, Rood L, Flowers E, Thayer S. Parenteral lorazepam versus parenteral haloperidol for the control of psychotic disruptive behavior. J Clin Psychiatry. 1991 Apr; 52(4):177-80.
-
Watsky EJ, Salzman C. Psychotropic drug interactions. Hosp Community Psychiatry. 1991 Mar; 42(3):247-56.
-
Salzman C. The APA Task Force report on benzodiazepine dependence, toxicity, and abuse. Am J Psychiatry. 1991 Feb; 148(2):151-2.
-
Salzman C, Lebowitz B. Anxiety in the Elderly. 1991.
-
Salzman C. [Benzodiazepines in medical practice. Report of the Study Group of the American Psychiatric Society (APA Task Force) on dependence, toxicity and abuse of benzodiazepines]. Nervenarzt. 1991 Jan; 62(1):61-3.
-
Salzman C. Anxiety in the elderly: treatment strategies. J Clin Psychiatry. 1990 Oct; 51 Suppl:18-21; discussion 29-32.
-
Salzman C. Mandatory monitoring for side effects. The "bundling" of clozapine. N Engl J Med. 1990 Sep 20; 323(12):827-9.
-
Salzman C. Notes from a state mental health directors' meeting on clozapine. Hosp Community Psychiatry. 1990 Aug; 41(8):838-9, 842.
-
Salzman C. Antidepressants. Clin Geriatr Med. 1990 May; 6(2):399-410.
-
Green AI, Salzman C. Clozapine: benefits and risks. Hosp Community Psychiatry. 1990 Apr; 41(4):379-80.
-
Salzman C, Miyawaki EK, Soloman D. Use of benzodiazepines. Hosp Community Psychiatry. 1990 Mar; 41(3):334.
-
Kingsbury SJ, Salzman C. Disulfiram in the treatment of alcoholic patients with schizophrenia. Hosp Community Psychiatry. 1990 Feb; 41(2):133-4.
-
Solomon DA, Miyawaki E, Salzman C. Benzodiazepine augmentation of the treatment of disruptive psychotic behavior. Prog Drug Res. 1990; 35:139-49.
-
Salzman C. Benzodiazepine Dependence, Toxicity, and Abuse: A Task Force Report of the American Psychiatric Association. 1990.
-
Salzman C. Practical considerations in the pharmacologic treatment of depression and anxiety in the elderly. J Clin Psychiatry. 1990 Jan; 51 Suppl:40-3.
-
Green AI, Bennett MB, Salzman C. An extramural training program in psychopharmacology: one model for a state system. Hosp Community Psychiatry. 1989 Feb; 40(2):126-7.
-
Salzman C. Use of benzodiazepines to control disruptive behavior in inpatients. J Clin Psychiatry. 1988 Dec; 49 Suppl:13-5.
-
Salzman C. Treatment of the agitated demented elderly patient. Hosp Community Psychiatry. 1988 Nov; 39(11):1143-4.
-
Plasky P, Marcus L, Salzman C. Effects of psychotropic drugs on memory: Part 2. Hosp Community Psychiatry. 1988 May; 39(5):501-2.
-
Marcus L, Plasky P, Salzman C. Effects of psychotropic drugs on memory: Part 1. Hosp Community Psychiatry. 1988 Mar; 39(3):255-6.
-
Shader RI, Harmatz JS, Salzman C. Sandoz Clinical Assessment-Geriatric (SCAG). Psychopharmacol Bull. 1988; 24(4):765-9.
-
Salzman C. Treatment of agitation, anxiety, and depression in dementia. Psychopharmacol Bull. 1988; 24(1):39-42.
-
Salzman C. Treatment of the elderly agitated patient. J Clin Psychiatry. 1987 May; 48 Suppl:19-22.
-
Glassman R, Salzman C. Interactions between psychotropic and other drugs: an update. Hosp Community Psychiatry. 1987 Mar; 38(3):236-42.
-
Salzman C, Green AI, Rodriguez-Villa F, Jaskiw GI. Benzodiazepines combined with neuroleptics for management of severe disruptive behavior. Psychosomatics. 1986 Jan; 27(1 Suppl):17-22.
-
Salzman C. Caution urged in using MAOIs with the elderly. Am J Psychiatry. 1986 Jan; 143(1):118-9.
-
Salzman C. Clinical guidelines for the use of antidepressant drugs in geriatric patients. J Clin Psychiatry. 1985 Oct; 46(10 Pt 2):38-45.
-
Salzman C. Clinical use of antidepressant blood levels and the electrocardiogram. N Engl J Med. 1985 Aug 22; 313(8):512-3.
-
Salzman C. Geriatric psychopharmacology. Annu Rev Med. 1985; 36:217-28.
-
Ratey JJ, Salzman C. Recognizing and managing akathisia. Hosp Community Psychiatry. 1984 Oct; 35(10):975-7.
-
Mills MJ, Pearsall DT, Yesavage JA, Salzman C. Electroconvulsive therapy in Massachusetts. Am J Psychiatry. 1984 Apr; 141(4):534-8.
-
Weinberger DR, Salzman C. Brain imaging techniques and their usefulness in psychiatry. Hosp Community Psychiatry. 1984 Apr; 35(4):325-6.
-
Glick I, Janowsky D, Salzman C, Shader R. A Model Psychopharmacology Curriculum for Psychiatric resident. 1984.
-
Salzman C. Clinical Geriatric Psychopharmacology. 1984.
-
Salzman C, Hoffman SA. Clinical interaction between psychotropic and other drugs. Hosp Community Psychiatry. 1983 Oct; 34(10):897-902.
-
Salzman C, Shader RI, Greenblatt DJ, Harmatz JS. Long v short half-life benzodiazepines in the elderly. Kinetics and clinical effects of diazepam and oxazepam. Arch Gen Psychiatry. 1983 Mar; 40(3):293-7.
-
Salzman C. Allocation of professional practice time. Arch Gen Psychiatry. 1982 Apr; 39(4):489-90.
-
Salzman C. Key concepts in geriatric psychopharmacology. Altered pharmacokinetics and polypharmacy. Psychiatr Clin North Am. 1982 Apr; 5(1):181-90.
-
Salzman C. Electroconvulsive therapy in the elderly patient. Psychiatr Clin North Am. 1982 Apr; 5(1):191-7.
-
Salzman C. Basic principles of psychotropic drug prescription for the elderly. Hosp Community Psychiatry. 1982 Feb; 33(2):133-6.
-
Salzman C. A primer on geriatric psychopharmacology. Am J Psychiatry. 1982 Jan; 139(1):67-74.
-
Salzman C. Psychotropic drug use and polypharmacy in a general hospital. Gen Hosp Psychiatry. 1981 Mar; 3(1):1-9.
-
Salzman C. The use of ECT in the treatment of schizophrenia. Am J Psychiatry. 1980 Sep; 137(9):1032-41.
-
Salzman C, van der Kolk B. Psychotropic drug prescriptions for elderly patients in a general hospital. J Am Geriatr Soc. 1980 Jan; 28(1):18-22.
-
Salzman C. Update on geriatric psychopharmacology. Geriatrics. 1979 Aug; 34(8):87-90.
-
Salzman C, van der Kolk BA. Management of the geriatric patient in a general hospital. Psychotropic drugs and polypharmacy in elderly patients in a general hospital. J Geriatr Psychiatry. 1979; 12(2):167-76.
-
Ciraulo D, Lind L, Salzman C, Pilon R, Elkins R. Sodium nitroprusside treatment of ECT-induced blood pressure elevations. Am J Psychiatry. 1978 Sep; 135(9):1105-6.
-
Salzman C, Shader RI. Depression in the elderly. II. Possible drug etiologies; differential diagnostic criteria. J Am Geriatr Soc. 1978 Jul; 26(7):303-8.
-
Salzman C, Shader RI. Depression in the elderly. I. Relationship between depression, psychologic defense mechanisms and physical illness. J Am Geriatr Soc. 1978 Jun; 26(6):253-60.
-
Pildis MJ, Soverow GJ, Salzman C, Wolf JG. Day hospital treatment of borderline patients: a clinical perspective. Am J Psychiatry. 1978 May; 135(5):594-6.
-
Shader RI, Elkins R, Ciraulo D, Salzman C. On guidelines for maximum dosages. Am J Psychiatry. 1978 Apr; 135(4):499-500.
-
Kochansky GE, Salzman C, Shader RI, Harmatz JS, Ogletree AM. Effects of chlordiazepoxide and oxazepam administration on verbal hostility. Arch Gen Psychiatry. 1977 Dec; 34(12):1457-9.
-
Salzman C. ECT and ethical psychiatry. Am J Psychiatry. 1977 Sep; 134(9):1006-9.
-
Salzman C, Kochansky GE, Van Der Kolk BA, Shader RI. The effect of marijuana on small group process. Am J Drug Alcohol Abuse. 1977; 4(2):251-5.
-
Salzman C, Van Der Kolk BA, Shader RI. Marijuana and hostility in a small-group setting. Am J Psychiatry. 1976 Sep; 133(9):1029-33.
-
Salzman C, Hoffer A, Shader RI. Alumni of the Massachusetts mental health center residency training. Arch Gen Psychiatry. 1976 Apr; 33(4):421-3.
-
Salzman C. Interpersonal problems in narcolepsy. Psychosomatics. 1976; 17(1):49-51.
-
Salzman C, Shader RI, Van der Kolk BA. Clinical psychopharmacology and the elderly patient. N Y State J Med. 1976 Jan; 76(1):71-7.
-
Salzman C, Shader RI, Harmatz J, Robertson L. Psychopharmacologic investigations in elderly volunteers: Effect of diazepam in males. J Am Geriatr Soc. 1975 Oct; 23(10):451-7.
-
Salzman C, Shader RI, Harmatz JS. Response of the elderly to psychotrophic drugs: predictable or idiosyncratic? Psychopharmacol Bull. 1975 Oct; 11(4):48-50.
-
Kochansky GE, salzman C, Shader RI, Harmatz JS, Ogeltree AM. The differential effects of chlordiazepoxide and oxazepam on hostility in a small group setting. Am J Psychiatry. 1975 Aug; 132(8):861-3.
-
Kochansky GE, Hemenway TS, Salzman C, Shader RI. Methaqualone abusers: a preliminary survey of college students. Dis Nerv Syst. 1975 Jul; 36(7):348-51.
-
Salzman C, Kochansky GE, Shader RI, Harmatz JS, Ogletree AM. Is oxazepam associated with hostility? Dis Nerv Syst. 1975 May; 36(5 Pt. 2):30-2.
-
Shader RI, Greenblatt DJ, Salzman C, Kochansky GE, Harmatz JS. Benzodiazepines: Safety and toxicity. Dis Nerv Syst. 1975 May; 36(5 Pt. 2):23-6.
-
Salzman C, Kochansky GE, Shader RI, Porrino LJ, Harmatz JS, Swett CP. Chlordiazepoxide-induced hostility in a small group setting. Arch Gen Psychiatry. 1974 Sep; 31(3):401-5.
-
Chessen DH, Geha DG, Salzman C. ECT, glaucoma, and prolonged apnea. Dis Nerv Syst. 1974 Apr; 35(4):152-3.
-
Shader RI, Harmatz JS, Salzman C. A new scale for clinical assessment in geriatric populations: Sandoz Clinical Assessment--Geriatric (SCAG). J Am Geriatr Soc. 1974 Mar; 22(3):107-13.
-
Salzman C, Shader RI. Psychopharmacology in the aged. Research considerations in geriatric psychopharmacology. J Geriatr Psychiatry. 1974; 7(2):165-84.
-
Reiss D, Salzman C. Resilience of family process. Effect of secobarbital. Arch Gen Psychiatry. 1973 Mar; 28(3):425-33.
-
Salzman C, Lieff J, Kochansky GE, Shader RI. The psychology of hallucinogenic drug discontinuers. Am J Psychiatry. 1972 Dec; 129(6):755-61.
-
Salzman C, Kochansky GE, Shader RI. Rating scales for geriatric psychopharmacology--a review. Psychopharmacol Bull. 1972 Jul; 8(3):3-50.
-
Salzman C, Shader RI, Kochansky GE, Cronin DM. Rating scales for psychotropic drug research with geriatric patients. I. Behavior ratings. J Am Geriatr Soc. 1972 May; 20(5):209-14.
-
Salzman C, Kochansky GE, Shader RL, Cronin DM. Rating scales for psychotropic drug research with geriatric patients. II. Mood ratings. J Am Geriatr Soc. 1972 May; 20(5):215-21.
-
Harmatz JS, Shader RI, Salzman C. Marihuana users and nonusers. Personality test differences. Arch Gen Psychiatry. 1972 Feb; 26(2):108-12.
-
Salzman C, Shader RI, Scott DA, Binstock W. Interviewer anger and patient dropout in walk-in clinic. Compr Psychiatry. 1970 May; 11(3):267-73.
-
Waskow IE, Olsson JE, Salzman C, Katz MM. Psychological effects of tetrahydrocannabinol. Arch Gen Psychiatry. 1970 Feb; 22(2):97-107.
-
Salzman C, Strauss ME, Engle RP, Kamins L. Overnight "guesting" of day hospital patients. Compr Psychiatry. 1969 Sep; 10(5):369-75.
-
Salzman C, DiMascio A, Shader RI, Harmatz JS. Chlordiazepoxide, expectation and hostility. Psychopharmacologia. 1969; 14(1):38-45.
-
Gardos G, DiMascio A, Salzman C, Shader RI. Differential actions of chlordiazepoxide and oxazepam on hostility. Arch Gen Psychiatry. 1968 Jun; 18(6):757-60.
-
DiMascio A, Shader RI, Salzman C, Harmatz JS. An evaluation of isoquinazepon (SAH-1123). Curr Ther Res Clin Exp. 1967 Oct; 9(10):517-21.
-
Salzman C, Shader RI, DiMascio A. Collagen disease-like syndrome following administration of a benzodiazepine derivative. Dis Nerv Syst. 1967 Sep; 28(9):614-5.